CIR News In Brief: No Conclusion Reached On PHMB; Endocrine Activity Guidance; More

At its Sept. 11-12 meeting in Washington, the Cosmetic Ingredient Review Expert Panel finalized reports for various protein and peptide ingredient families, among others, and advanced six tentative reports. The panel issued a tentative insufficient data conclusion for broad-spectrum preservative polyaminopropyl biguanide, with concerns about sensitization continuing to weigh on the group.

The Cosmetic Ingredient Review Expert Panel issued seven final reports at its Sept. 11-12 meeting in Washington, finding all of the ingredient groups safe as used, with some isolated ingredient exceptions and caveats. Three families of protein and peptide ingredients – predominantly used as skin- and hair-conditioning ingredients in cosmetics – were among those assessed, along with shea-derived ingredients, polyurethanes and others. (Also see "Cosmetic Ingredient Review Report Status" - HBW Insight, 19 September, 2017.) Meanwhile, six tentative reports advanced, all with "safe as used" findings except Mentha piperita (peppermint)-derived ingredients, which require additional data overall, and polyaminopropyl biguanide, for which data also were deemed insufficient, according to the post-meeting announcement.

Separate from tentative reports with insufficient data conclusions, two insufficient data announcements emerged from the CIR panel meeting – for...

More from Ingredients & Safety

Pharma Deutschland Seeks To Enter Urban Wastewater Legal Dispute

The Urban Wastewater Treatment Directive “in its current form, is at an end,” insists Pharma Deutschland CEO Jörg Wieczorek. To put the directive to bed once and for all, the association has applied for leave to intervene in the ongoing EU legal battle in its own right.

UK FSA Issues New Guidelines For CBD And THC Max Levels

 
• By 

Based on advice from its advisory committees, the UK's Food Standards Agency is encouraging businesses to meet an acceptable daily intake of 10mg CBD per day and a safe upper limit of 0.07mg THC per day.

AESGP Annual Meeting: Harmonizing EU VMS Max Levels Could Cost Sector Over €200m

 
• By 

Limited capacity and a two-to-three year timescale for reformulation could mean that many VMS supplements disappear from the market, warns EPPA partner Alexandra Bocquillion, speaking at the AESGP Annual Meeting in Warsaw, Poland.

EU Pharma Reform: Council Proposes Rx Exemption For Topical Antimicrobials

 
• By 

The EU Council has introduced a key amendment to Article 51 (para 1, point e) of the new pharma directive: “A medicinal product shall be subject to medical prescription where it is an antimicrobial, unless intended for topical use.”

More from HBW Insight